Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curahealth Hospitals was a U.S. post-acute healthcare company that operated long-term acute care hospitals and inpatient rehabilitation facilities rather than a biotech or pharmaceutical development business. The company focused on medically complex patients requiring extended hospital-level recovery, including respiratory therapy, dialysis, telemetry, and multidisciplinary rehabilitation services. Curahealth expanded in part through hospital acquisitions, including facilities acquired from Kindred Healthcare and HCA. In October 2024, PAM Health announced the acquisition of 16 specialty hospitals from Curahealth and Nautic Partners, indicating that Curahealth as an independent hospital operator has largely been absorbed into PAM Health. For a biotech analyst, this is a healthcare services provider with no evident drug pipeline, R&D platform, or therapeutic asset portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curahealth Hospitals.